Cancer Clinical Trials Financial Reimbursement Program
Part of paid clinical trials in Dallas, Texas.
- Sponsor
- University of Texas Southwestern Medical Center
- Study ID
- NCT05402033
- Status
- Recruiting
Conditions
- Cancer Clinical Trials
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Survey / Interview Group — BEHAVIORALPatients with any cancer type who are informed that they may be eligible for participation in any phase therapeutic cancer clinical trial by their treating physician (typically a clinical oncologist) will be provided information about the Financial Reimbursement Program. Patients who enroll to therapeutic cancer clinical trial will be eligible for the reimbursement program and offered an opportunity to participate in this study.
Study Details
To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.
Key Dates
- Start date
- Jul 12, 2022
- Status verified
- Sep 2025
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 1,200 participants (estimated)
Arms
- Arm: Survey / Interview GroupAll patients (or parent / caregiver, if relevant) who provide informed consent will be asked to complete baseline assessments utilizing validated questionnaires administered through the phone or video call. The clinical research coordinator will input responses into REDCap. Alternatively, patients may request assessments be sent through secure email. Baseline assessment consisting of sociodemographic items and study eligibility questions (call #1) In addition, each patient will complete the Comprehensive Score for financial Toxicity Patient Reported Outcome Measure (COST PROM) and Short Assessment of Health Literacy (SAHL) survey measures.
Primary Outcome Measure
Clinical trial enrollment retention rate measured by COST PROM [ Time Frame: Up to first 60 days after enrollment to a therapeutic cancer trial. ]
Central Contacts
- Rebecca Renn214-648-7097
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | David E Gerber, MD |
Find similar trials in Dallas, TX
By research site